Home » Discovery Labs’ KL4 Surfactant Granted Orphan Drug Designation
Discovery Labs’ KL4 Surfactant Granted Orphan Drug Designation
Discovery Laboratories, Inc. Monday announced that the Office of Orphan Products Development of the United States Food and Drug Administration has granted orphan drug designation to Discovery’s KL4 surfactant for the treatment of cystic fibrosis.
Forbes
Forbes
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May